McKesson joins USD 5.8 billion deal: McKesson stock keeps guidance

Published on 10/27/2026 at 11:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson joins a USD 5.8 billion Option Care deal. McKesson stock trades at EUR 895.50 on October 27, 2026, with results due November 4, 2026.

Option Care expansion and earnings date

McKesson joined a USD 5.8 billion Option Care Health acquisition announced on October 6, 2026.
Fiscal 2027 adjusted earnings guidance stands at USD 44.20-45.00 per share.
McKesson stock trades at EUR 895.50 at 11:15 a.m. CEST at Lang & Schwarz on October 27, 2026.

McKesson, US58155Q1031, Illustration mit AI erstellt.

McKesson joined a USD 5.8 billion agreement to acquire Option Care Health, with McKesson stock at EUR 895.50 at Lang & Schwarz on October 27, 2026. Yahoo Finance reported the transaction on October 9, 2026, citing a total enterprise value of USD 5.8 billion.

Specialty care drives the deal

The transaction would broaden McKesson's presence in home and alternate-site infusion services. The acquisition follows fiscal 2027 first-quarter revenue of USD 105.38 billion, up 7.70 percent from the prior-year quarter, while adjusted earnings per share reached USD 9.93, a 20.00 percent increase. Zacks reported the figures on September 4, 2026.

McKesson's Oncology and Multispecialty revenue rose 33.00 percent to USD 14.22 billion in that quarter, while adjusted segment operating profit increased 41.00 percent to USD 405 million. The figures show why specialty distribution is central to the Option Care rationale.

What comes next for earnings?

Business Wire reported on October 1, 2026, that McKesson reaffirmed fiscal 2027 adjusted earnings guidance of USD 44.20-45.00 per share and a long-term adjusted earnings growth target of 13.00-16.00 percent. The company is scheduled to release second-quarter fiscal 2027 results after the market close on November 4, 2026, with its conference call at 4:30 p.m. ET.

Three dated company milestones

On August 5, 2026, McKesson reported USD 105.38 billion in first-quarter revenue and raised its fiscal 2027 adjusted earnings outlook. On October 1, 2026, it agreed in principle to extend its CVS Health distribution partnership through June 2032. On October 6, 2026, McKesson joined the Option Care Health acquisition valued at USD 5.8 billion.

Stock and valuation context

McKesson's primary listing is the NYSE. The latest structured market quote showed USD 992.87 on October 26, 2026, with a 52-week range of USD 723.68 to USD 1,030.27 and market capitalization of USD 115.8 billion. The euro quote gives German investors a separate trading reference.

Market perspective

McKesson was trading at EUR 895.50 at Lang & Schwarz on October 27, 2026 at 11:15 a.m. CEST. The quote was intraday, and no Xetra comparison is included.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.